about
BRCA1 is an essential regulator of heart function and survival following myocardial infarctionFluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculatureCulture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanismMyocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent.Detection of coronary stenosis and myocardial viability using a single intravenous bolus injection of BR14.Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound.Perfusion versus function: the ischemic cascade in demand ischemia: implications of single-vessel versus multivessel stenosis.Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography.Skin perfusion assessed by contrast ultrasound predicts tissue survival in a free flap model.Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo.Influence of microbubble shell properties on ultrasound signal: Implications for low-power perfusion imaging.Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins.Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.A1-receptor blockade: a novel approach for assessing myocardial viability in chronic ischemic cardiomyopathy.Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinomaThe Tie2-agonist Vasculotide rescues mice from influenza virus infectionOptimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy.Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles.Molecular imaging identifies regions with microthromboemboli during primary angioplasty in acute coronary thrombosis.Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia.Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression.Effect of microbubble exposure to ultrasound on quantitation of myocardial perfusion.Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstrictionAssessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping.Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles.Contrast echocardiography in Canada: Canadian Cardiovascular Society/Canadian Society of Echocardiography position paper.Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia.Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B)Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysisTreatment with a highly selective β₁ antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats.Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscleNocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function.Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study.Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation.Contrast echocardiography: putting things into perspective - a Canadian Cardiovascular Society/Canadian Society of Echocardiography joint commentaryAnti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol.Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy.
P50
Q24300290-B1325137-4BF1-43C8-BCB9-44CBD11D7919Q27320632-F55420B0-1DF8-45D9-A23C-56010FAAE0CDQ27333630-164782B4-7E88-4557-A389-8C208E96F7D5Q30308621-642951E7-A353-4245-A25D-6535DEEC338BQ30308622-68DB0C16-971E-44EB-BF1C-83C7E37B914EQ30308648-2C1AB5CB-0919-4353-ACEE-825B5DEED5C7Q30308800-F051F47F-C49A-41ED-8C90-0E4DC5B73952Q30309235-D7F4E17A-B923-4D81-9F4D-024716C5DD2EQ30309265-64428D08-1ECA-4E27-AFA9-6670E067365FQ30309674-299E9DA9-2660-4061-BCAB-217A64FDD0D8Q30310184-B802E2B8-A4CD-434A-9679-ED803204AC1FQ30310391-6D9F32F5-5BE8-48B6-AF7A-182F58CF2D4DQ30310466-0AA0FAC2-BE0B-47FD-99DE-3B84D0557F3EQ30310994-39C2B92F-E74F-49EF-A38D-DD5B4465D1D3Q30310995-A2A159A4-3191-41FE-A684-3DC63D9FC053Q30360377-CB442427-7FD9-4C08-A89D-25FEE24A513AQ30375351-FD5EB4CA-76F7-4150-AA19-5EAD31609BB7Q30385729-E9519BE0-FEE7-4324-88EC-3691F78DDF4BQ30416117-AED2BAC4-295F-475C-8B18-C284743BA6EEQ30433895-46827639-09EF-4788-B333-25DEA1EABD89Q30435920-F9C0CF94-769C-4AB9-A6DC-713ABBE9360FQ30437120-918EC5AC-8AE8-44F6-A707-BD9998E7BB87Q30437175-1F9211FC-F32F-4A5A-9C20-F6CAE64841A9Q30443269-8E6172CD-8693-4014-9A60-F14D8940403BQ30443850-D7AC348B-C7D2-4C2F-90D8-3683CDA22FA5Q30489494-A4294A48-451E-4A9B-88EF-B34E91B7B914Q30490646-A1C26E14-6FDD-4EBB-9410-CE4EB49C008CQ33367376-44CFE7AB-C33D-4579-A317-63D211126449Q33421226-EDB1B6C6-7EB3-46A0-91AC-5CA35EF51B0BQ33592854-3B8026F1-A068-4C5B-A414-0001DEB2D3F4Q34133189-B4210F2F-1CFD-458B-BA5D-FEAC8EA67403Q34582802-DB8525DE-43D9-49B9-8A31-910FE679517AQ34994515-416EAB15-87B6-4D3C-97B6-2AD9EFA9EEA0Q35030600-7BF02466-E977-44D1-8DC8-ED6DED6E8FD6Q35272436-96671711-D51E-4FB2-A44E-6F01C51059A3Q35903365-3256C73B-47C0-4039-A1CB-94F436B3A1FAQ36351055-F257CE66-3460-4F46-805F-735AB5F1AF6BQ37318773-16A46236-DED6-4700-BCF5-1CDD5129EFACQ37402717-E69D265D-C808-4231-B50B-74B1D29507CCQ37560413-431A3CB7-93C4-426E-BEBE-2A1D5BAC04FA
P50
name
Howard Leong-Poi
@ast
Howard Leong-Poi
@en
Howard Leong-Poi
@nl
type
label
Howard Leong-Poi
@ast
Howard Leong-Poi
@en
Howard Leong-Poi
@nl
prefLabel
Howard Leong-Poi
@ast
Howard Leong-Poi
@en
Howard Leong-Poi
@nl